familymednews.com
People with high blood pressure who get on the information highway can avoid roadblocks in their cardiovascular health, according to new research. The study found that adding online counseling to medical therapy helped lower high blood pressure and the estimated risk for developing heart disease within the next decade. “Internet-based supportive lifestyle counseling does indeed work effectively when it’s clinically […]
Continue reading »
For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia (AML) to understand how this blood cancer responds to a new drug, enasidenib. The work also explains what happens when a patient stops responding to the treatment, providing important clues about how to combine enasidenib with other anti-cancer drugs […]
Continue reading »
Infections like Nipah virus and Ebola have begun to appear more rapidly among human populations over the past twenty years, but experts have yet to conclude why this may be the case. In India, the lesser-known Nipah virus has been part of a recurrent outbreak since the late 1990s, where it has a high case fatality rate of 40 to […]
Continue reading »
During the five years before people develop the first clinically recognized signs of multiple sclerosis (MS), they are up to four times more likely to be treated for nervous system disorders such as pain or sleep problems, and are 50 per cent more likely to visit a psychiatrist, according to new research from the University of British Columbia. The study, […]
Continue reading »
THOUSAND OAKS, Calif. and BRUSSELS, July 12, 2018 /PRNewswire/ — Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced the resubmission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Evenity™* (romosozumab), an investigational monoclonal antibody for the treatment of osteoporosis in postmenopausal women at high risk for fracture. Evenity increases bone formation and […]
Continue reading »
Two fruit flies meet in an acrylic mating chamber and check each other out. It’s the insect version of speed dating for science. The male taps the female with his leg, which is studded with pheromone-sensing receptors. He then might doggedly follow her around and serenade her with a song by sticking out a wing and vibrating it. But before […]
Continue reading »
(HealthDay)—Higher levels of vitamin D may be protective against breast cancer, according to a study published online June 15 in PLOS ONE. Sharon L. McDonnell, M.P.H., from GrassrootsHealth in Encinitas, Calif., and colleagues examined the relationship between 25-hydroxyvitamin D (25[OH]D concentration and breast cancer risk across a broad range of 25(OH)D concentrations (
Continue reading »
(HealthDay)—The type 2 diabetes tide remains unchecked in the United States, as does pre-diabetes—having a blood sugar level higher than normal, but not high enough for a diabetes diagnosis. A U.S. Centers for Disease Control and Prevention report found that about 30 million Americans—roughly 10 percent of the population—have type 2 diabetes. What’s more, over 80 million have pre-diabetes, which, […]
Continue reading »
Athletes who have attention deficit hyperactivity disorder (ADHD) may be at greater risk for experiencing persistent anxiety and depression after a concussion than people who do not have ADHD, according to a preliminary study released today that will be presented at the American Academy of Neurology’s Sports Concussion Conference in Indianapolis, July 20 to 22, 2018. ADHD is a brain […]
Continue reading »
Supplementing a single protein found in the spinal cord could help prevent symptoms of Lou Gehrig’s disease, according to a new study out of Case Western Reserve University School of Medicine. Researchers found high levels of the protein—called mitofusion 2 or Mfn2—prevented nerve degeneration, muscle atrophy, and paralysis in a mouse model of the disease. Since Mfn2 is often depleted […]
Continue reading »